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Active Transport of an
Antibiotic Rifamycin Derivative by the
Outer-Membrane Protein FhuA
which is not a FhuA-specific ligand and permeates
across the cell envelope by passive diffusion only.
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Universita¨t Konstanz The uptake of antimicrobial agents across the outer
membrane of gram-negative bacteria is mediated byKonstanz D-78457
Germany a family of transport proteins employing a variety of
mechanisms. Small hydrophilic solutes, primarily ions2 Howard Hughes Medical Institute
Department of Biochemistry and sugars, are taken up into the periplasm by passive
diffusion through nonspecific and substrate-specificUniversity of Texas Southwestern Medical Center
Dallas, Texas 75390 porins. The structural architecture of bacterial porins,
with their apparent exclusion limit of approximately 6003 Department of Microbiology and Immunology
McGill University Da, and the electrostatic arrangement of charged side
chains lining porin channels contribute to the exclusionMontre´al, Que´bec H3A 2B4
Canada of antibiotics from the cell interior [1]. When essential
molecules (600 Da) (including siderophores and vita-4 Lehrstuhl Mikrobiologie/Membranphysiologie
Universita¨t Tu¨bingen min B12) are present at low concentrations, they are
actively transported across the cell envelope. With theTu¨bingen D-72076
Germany exception of the Donnan potential, no permanent electri-
cal or chemical potential difference can be maintained
across the outer membrane. Moreover, no source of
energy has been localized in the periplasm. The chemi-Summary
cal energy needed to drive these energy-dependent
transport processes is provided by the electrochemicalBackground: FhuA, an integral membrane protein of
proton gradient maintained across the cytoplasmicEscherichia coli, actively transports ferrichrome and the
membrane [2]. The energy-transducing TonB-ExbB-structurally related antibiotic albomycin across the outer
ExbD complex couples the proton motive force of themembrane. The transport is coupled to the proton mo-
cytoplasmic membrane to a family of diverse outer-tive force, which energizes FhuA through the inner-
membrane proteins, the TonB-dependent transporters.membrane protein TonB. FhuA also transports the semi-
In E. coli, the ferric hydroxamate uptake receptor FhuAsynthetic rifamycin derivative CGP 4832, although the
actively transports the siderophores ferrichrome andchemical structure of this antibiotic differs markedly
ferricrocin, the cyclic peptide antibiotic microcin J25,from that of ferric hydroxamates.
the siderophore-antibiotic conjugate albomycin, and the
bacterial toxin colicin M across the outer membrane [3].Results: X-ray crystallography revealed that rifamycin
FhuA also functions as the primary receptor for bacterio-CGP 4832 occupies the same ligand binding site as
phages T1, T5, φ80, and UC-1.ferrichrome and albomycin, thus demonstrating a sur-
The determination of the three-dimensional structureprising lack of selectivity. However, the binding of rifa-
of FhuA was an important step toward understandingmycin CGP 4832 is deviant from the complexes of FhuA
the intricate structure-function relationships of this re-with hydroxamate-type ligands in that it does not result
ceptor and its energy-dependent transport mechanismin the unwinding of the switch helix but only in its desta-
[4, 5, 7]. FhuA is composed of two domains; a 22 strandbilization, as reflected by increased B factors. Unwind-
 barrel (residues 161–714) spans the outer membrane,ing of the switch helix is proposed to be required for
and longer extracellular loops and shorter periplasmicefficient binding of TonB to FhuA and for coupling the
turns connect adjacent, antiparallel transmembrane proton motive force of the cytoplasmic membrane with
strands. Part of the barrel interior is occluded by the corkenergy-dependent ligand transport. The transport data
domain, an amino-terminal globular domain (residuesfrom cells expressing mutant FhuA proteins indicated
1–160) composed of a mixed 4 strand  sheet and aconserved structural and mechanistic requirements for
series of short  helices. The residues that compose thethe transport of both types of compounds.
ligand binding site are located within a nonoccluded
portion of the  barrel, which is accessible from the
Conclusions: We conclude that the binding of rifamycin external solvent.
CGP 4832 destabilizes the switch helix and promotes FhuA possesses high affinity but limited structural
the formation of a transport-competent FhuA-TonB specificity for hydroxamate-type siderophores including
complex, albeit with lower efficiency than ferrichrome. ferrichrome, a cyclic hexapeptide composed of three
Active transport of this rifamycin derivative explains the
200-fold increase in potency as compared to rifamycin,
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-N-acetyl-L--N-hydroxyornithine and three glycine resi- Table 1. Data Collection and Refinement Statistics of FhuA in
dues. Structural alteration of the iron-chelating portion Complex with Rifamycin CGP 4832
of this siderophore abrogates receptor-specific recogni- Data Collection and Reduction
tion [6]. In contrast, structural analogs of ferrichrome
Space group P61that possess identical iron-chelating and distinct hy-
Unit celldrophobic peptide linkers, including ferricrocin and al-
a (A˚) 172.82
bomycin, are bound and transported by FhuA. Because b (A˚) 172.82
albomycin is actively transported across both the outer c (A˚) 87.91
and cytoplasmic membranes, it is one of the most potent Number of molecules per asymmetric unit 1
Number of measured reflections 161,168antibiotics against E. coli (minimal inhibitory concentra-
Number of unique reflections 33,363tion [MIC] of 0.005 g/ml). The three-dimensional struc-
Completeness (%) 99.9 (99.8)ture of FhuA in complex with albomycin [7] confirmed
Resolution (A˚) 2.90that this antibiotic occupies the same ligand binding
Rsym (%) 6.2 (29.8)site as ferrichrome, ferricrocin, and phenylferricrocin. Rmeas (%) 7.0 (33.5)
This similarity extends to the set of residues that are Rmerge-F (%) 7.2 (24.6)
involved in ligand binding and which are essentially con- I/I 17.2 (4.2)
served among these hydroxamate-type siderophores,
Structural Refinement
and it thereby provides a structural explanation for high-
Rwork (%) 23.3affinity binding.
Rfree (%) 27.5In 1987, Wehrli et al. [8] described a semisynthetic
Root-mean-square deviationrifamycin derivative, CGP 4832, that displayed at least Bond lengths (A˚) 0.008
a 200-fold increase in antimicrobial activity against E. Bond angles () 1.5
coli and Salmonella typhimurium as compared to the Dihedral angles () 25.9
clinically used drug rifamycin (Rifampicin). The en- Improper angles () 0.9
Mean B factor of the protein atoms (A˚2) 68.0hanced bactericidal activity of rifamycin CGP 4832 was
Mean B factor of the ligand atoms (A˚2) 98.7correlated with the ability of this antibiotic to be specifi-
cally transported into the periplasm by FhuA [9]. In con- Parentheses indicate the highest resolution shell.
trast to albomycin, rifamycin CGP 4832 is not actively
transported across the cytoplasmic membrane by
FhuBCD [9], which is an ABC transport system [10]. The
were derived from the isomorphous, unliganded struc-periplasmic binding protein FhuD and the cytoplasmic
ture (Figure 1; Table 1; [4]). After initial structural refine-membrane-embedded permease FhuBC effectively dis-
ment, a Fobs 	 Fcalc difference map showed clear electroncriminate between rifamycin CGP 4832 and the diverse
density for a single rifamycin CGP 4832 molecule lo-array of hydroxamate-type siderophores and antibiotics
cated within the extracellular pocket of FhuA (Figurethat are uniquely transported by this system [3]. Be-
cause the chemical structure of this rifamycin derivative
shares no structural similarities with ferrichrome or with
albomycin, we wished to determine how this antibiotic
is specifically recognized and transported by FhuA. To
establish whether it occupies the same ligand bind-
ing site as previously observed with hydroxamate-type
siderophores and to characterize any distinct ligand-
induced conformational changes, we determined the
three-dimensional structure of FhuA in complex with
rifamycin CGP 4832. Furthermore, we also studied the
binding of ligands to FhuA by fluorescence measure-
ments, transport inhibition, and selection of mutants
resistant to this antibiotic. Our findings reveal common
structural and mechanistic requirements for the energy-
dependent transport of structurally dissimilar FhuA-spe-
cific ligands. Moreover, this structural information provides
a basis for the rational design of synthetic antibiotics that
are actively transported by this receptor or by its homo-
logs. Because the outer membrane of gram-negative bac-
teria is inherently impermeable to polar substances 600
Da and therefore diffusional uptake is inefficient, such
receptor-specific bactericidal agents may increase the ef-
ficacy of chemotherapeutic agents [7].
Figure 1. FhuA-CGP 4832 ComplexResults
The view is perpendicular to the barrel axis. The  strands that form
the front of the barrel domain have been rendered semitransparent;
General Description of the Structure and the Rifamycin this provides an unobstructed view of the cork domain. The barrel
CGP 4832 Binding Site domain is colored blue, and the cork domain is yellow. The rifamycin
FhuA in detergent-containing solution was cocrystal- CGP 4832 molecule is shown as a bond model with carbon atoms
in white, oxygen atoms in red, and nitrogen atoms in blue.lized with rifamycin CGP 4832. Phases to 2.9 A˚ resolution
Transport of an Antibiotic by FhuA
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Figure 2. The FhuA Rifamycin CGP 4832
Binding Site
(a) Representative section of the electron
density map for the FhuA-CGP 4832 complex.
In this stereo view the final simulated anneal-
ing SIGMAA-weighted 2Fobs 	 Fcalc map
(green) at a resolution of 2.90 A˚ is contoured
at 1.2 ; this view shows the rifamycin CGP
4832 binding site. The rifamycin CGP 4832
molecule and select side chain residues are
shown with carbon atoms in yellow, oxygen
atoms in red, and nitrogen atoms in blue.
(b) The residues involved in the binding of
CGP 4832. Those side chains that form hy-
drogen bonds or van der Waals contacts with
rifamycin CGP 4832 atoms are labeled and
shown in green. The rifamycin CGP 4832 mol-
ecule is presented as a bond model with car-
bon atoms in white, oxygen atoms in red, and
nitrogen atoms in blue.
Figures 2a and 3 were prepared with the pro-
grams O [28] and ISIS Draw, respectively. All
other color figures were prepared with MOL-
SCRIPT [33] and Raster3D [34].
2a). Side chains from apices B and C of the cork domain Structural Comparison of the Ligand Binding
Sites of FhuA[4] and from the  barrel domain form hydrogen bonds,
charge interactions, and van der Waals contacts with The chemical structure of rifamycin CGP 4832 (Figure
3a) shows no obvious similarity with albomycin (Figurethe antibiotic (Figures 2b and 3a; Table 2). The addition
of morpholino and N-methyl-3-piperidyl-acetoxyacetyl 3b) and ferricrocin (Figure 3c). Moreover, the cork do-
main structure in the FhuA-CGP 4832 complex differsgroups structurally distinguishes rifamycin CGP 4832
from rifamycin; the latter is not actively transported by from that found in complexes with hydroxamate-type
siderophores and albomycin. By comparing the sideFhuA. Previous structure-function studies [8] demon-
strated that both chemical moieties are required for the chains involved in the binding of these structurally dis-
similar substrates, we identified signature residues thatrifamycin derivative to exert its bactericidal activity. Our
analysis of protein-ligand interactions between FhuA are involved in ligand binding (Table 3). The iron-chelat-
ing moiety of FhuA-specific hydroxamate-type sidero-and rifamycin CGP 4832 showed that the morpholino
and N-methyl-3-piperidyl-acetoxyacetyl groups form phores and albomycin is formed by three -N-acetyl-
L--N-hydroxyornithine peptides. This portion of themultiple hydrogen bonds, charge interactions, and van
der Waals contacts with FhuA side chains (Figures 2b siderophore forms multiple highly conserved interac-
tions with side chains from apices A, B, and C of theand 3a; Table 2). Chemical replacement of the morpho-
lino moiety by a methyl-piperazinyl-iminomethyl substit- cork domain, as well as with residues from the  strands
and extracellular loops of the barrel domain (Figures 3buent abolished the bactericidal activity of rifamycin CGP
4832 [9]. The structure indicated that substitution of and 3c). There are also contacts between the tripeptide
component of the siderophore (GGG [ferrichrome], GSGthe morpholino group would prevent the formation of a
critical hydrogen bond between rifamycin CGP 4832 and [ferricrocin], GFG [phenylferricrocin]) and the amino ace-
tyl thioribosyl pyrimidine moiety of albomycin, with sideY116 from apex C and would thereby abrogate high-
affinity binding. chains of the extracellular pocket (Table 3). A similar set
Structure
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Table 2. Interactions of FhuA with Rifamycin CGP 4832
Residue Atom Location Distance Type of Interaction
E98-OE2 Apex B 3.7 A˚ charge interactions with O8 carbonyl atom of the N-methyl-3-piperidyl-
acetoxyacetyl group
E98-O Apex B 3.8 A˚ charge interactions with O20 carbonyl atom of the N-methyl-3-piperidyl-
acetoxyacetyl group
G99-NH Apex B 3.7 A˚ charge interactions with O20 carbonyl atom
Q100-OE1 Apex B 3.5 A˚ Van der Waals contact with the C5 methyl group
S101-OG Apex B 3.5 A˚ Hydrogen bond with O20 carbonyl atom
F115-O Apex C 3.0 A˚ Van der Waals contact with C55 atom of the piperidyl group
Y116-OH Apex C 3.2 A˚ hydrogen bond with O18 atom of the morpholino group
Y244-OH L3 3.9 A˚ charge interactions with N6 atom
W246-CZ2 L3 3.6 A˚ Van der Waals contact with the aromatic-ring system (distance given is for
the O17 atom)
Y313-OH 7 3.6 A˚ charge interactions with N4 atom
Y315-OH L4 2.8 A˚ hydrogen bond with O1 carbonyl atom of the aromatic-ring system
K344-CD 8 3.4 A˚ Van der Waals contact with C24 methyl group
F391-CE2 9 3.0 A˚ Van der Waals contact with O18 atom of the morpholino group and the
C31 and C32 methyl groups
G392-O 9 3.2 A˚ Van der Waals contact with C24 methyl group
Y423-OH 10 3.3 A˚ Van der Waals contact with the C31 and C32 methyl groups
Q505-NE2 L7 3.0 A˚ hydrogen bond with the O8 carbonyl atom of the N-methyl-3-piperidyl-
acetoxyacetyl group
F693-CE1 L11 3.5 A˚ Van der Waals contact with the aromatic-ring system (distance given is for
C40 atom)
Y696-OH L11 3.0 A˚ hydrogen bond with O2 hydroxyl atom
Listed are the residue atoms, locations, distances, and types of interactions formed by all FhuA side chain residues within 4 A˚ of rifamycin
CGP 4832 atoms. See Figure 3a for structural details of the hydrogen bonding pattern and charge interactions between side chains and
rifamycin CGP 4832.
of side chains also forms contacts with rifamycin CGP bonds formed between periplasmic turns 8 and 9 and
this helix and thereby promotes its unwinding. As a re-4832. However, there is one notable exception: R81 from
apex A does not interact with the antibiotic. In the bind- sult, all residues NH2-terminal of R31 assume an ex-
tended conformation within the periplasmic pocket. Ining site for hydroxamate-type ligands, this residue forms
multiple hydrogen bonds with the iron-chelating compo- contrast, apex A in the FhuA-CGP 4832 complex remains
fixed 4.6 A˚ away from the nearest ligand atom, as in thenent of the siderophore. In the FhuA-CGP 4832 complex,
the guanidinium group of R81 is placed 4.6 A˚ away from unliganded conformation. No upward movement of this
cork domain loop is induced, and therefore the switchthe nearest rifamycin CGP 4832 atom and thus forms
only weak charge interactions with the derivative. helix remains wound. However, the increase in relative
B factors of the C atoms composing the switch helix
suggests that this segment is destabilized when rifamy-Ligand-Induced Allosteric Transitions
Structural superposition of the C atoms of unliganded cin CGP 4832 binds (Figure 4). The allosteric transition
induced by this antibiotic thus differs from those ob-FhuA and FhuA liganded with rifamycin CGP 4832, fer-
richrome, ferricrocin, phenylferricrocin, or albomycin re- served with other liganded complexes of FhuA.
To confirm these unexpected crystallographic obser-vealed almost perfect superposition of the  barrel do-
mains (0.25 A˚ root-mean-square deviation of C atoms). vations, we collected intrinsic tryptophan fluorescence
measurements with detergent-solubilized FhuA. In ac-However, a comparison of the C atoms of the cork
domain identified three distinct conformations: the hy- cord with Locher and Rosenbusch [11], we found that
the addition of ferrichrome to purified, detergent-solubi-droxamate-type unliganded, the liganded, and the CGP
4832-liganded conformations. The transition from the lized FhuA decreased the emitted intrinsic tryptophan
fluorescence of the receptor. A slight decrease in trypto-unliganded to the hydroxamate-type liganded confor-
mation reveals the following induced-fit binding mecha- phan fluorescence upon the binding of rifamycin CGP
4832 or desferriferrichrome was also observed (Figurenism [4, 5, 7]: residues 80–82 of apex A and 98–100 of
apex B moved by 0.7–2.0 A˚ toward the siderophore or 5a). Unexpectedly, the addition of ferrichrome to a tryp-
tophan solution of equivalent concentration also de-albomycin. In the transition to the CGP 4832-liganded
conformation, only residues 97–100 from apex B moved creased the emitted fluorescence (Figure 5b). However,
the magnitude of the fluorescence quenching was notupward (0.5–1.5 A˚) to interact with the antibiotic (Table
2). All other cork domain residues remained stationary. equivalent to that observed with FhuA. The addition of
rifamycin CGP 4832 or desferriferrichrome to the trypto-In the complexes with iron-hydroxamates, the upward
translation of apex A is propagated to all cork domain phan solution also failed to produce a similar effect
(Figure 5b).loops between this point and the periplasmic pocket of
FhuA. The translation of apex A and other cork domain A second biophysical method for monitoring ligand-
induced structural transitions in FhuA was provided byloops alters the shape of the hydrophobic pocket of the
switch helix (residues 24–29), disrupts several hydrogen the measurement of fluorescence changes of fluores-
Transport of an Antibiotic by FhuA
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cein-labeled cysteine residues. This technique has ad-
vantages in that the location of the reporter is known
and in that data can be collected directly from viable,
intact cells. It was shown previously [12] that ferrichrome
binding to FhuA quenched the emitted fluorescence of
two fluorescein-labeled cysteines, residues 329 and
336, which are located in the fourth extracellular loop
according to the three-dimensional structure of FhuA.
Rifamycin CGP 4832 binding caused a similar reduction
in fluorescence of both surface-exposed cysteines.
However, a 100-fold higher concentration of rifamycin
CGP 4832 was required to obtain a similar ferrichrome
bound spectrum (Table 4). The observed fluorescence
quenching by rifamycin CGP 4832 was not a function of
the TonB-dependent transport of this antibiotic through
FhuA since identical spectra were obtained from tonB-
deleted background strains (data not shown). The bind-
ing of ferrichrome to FhuA also induced a similar TonB-
independent shift in fluorescence [12].
Rifamycin CGP 4832 Competes with Ferrichrome
for Binding to the Ligand Binding Site of FhuA
To probe the functional implications resulting from the
similarity of the binding sites for rifamycin CGP 4832
and ferrichrome, we performed transport inhibition
assays. The addition of 10, 30, or 100 g/ml of rifamycin
CGP 4832 produced a 50%, 75%, or 85% reduction in
the [55Fe3
]-ferrichrome transport rate (Figure 6). These
data indicate that this antibiotic competes with fer-
richrome for the same binding site and that both sub-
strates have similar binding affinities. Because rifamycin
CGP 4832 does not use the FhuBCD ferrichrome trans-
port system across the cytoplasmic membrane, com-
petitive transport inhibition is confined to passage
across the outer membrane only [9].
Bacterial Mutants Resistant to Rifamycin
CGP 4832
To determine if the energy-dependent transport of rifa-
mycin CGP 4832 and ferrichrome share common struc-
tural requirements, we assessed the sensitivity for the
antibiotic of cells expressing FhuA proteins with known
point mutations in their TonB boxes (residues 6–11);
these mutations all exhibit impaired TonB-related FhuA
activity [13]. Plasmid-encoded fhuA genes were used
to transform E. coli UL3, which does not synthesize a
wild-type FhuA protein. In contrast to cells expressing
wild-type FhuA, those producing FhuA mutants I9P or
V11D showed resistance to 0.4–10 g/ml of rifamycin
CGP 4832. The antibiotic sensitivity of mutant and wild-
type cells for rifamycin CGP 4832 and rifamycin were
Figure 3. Ligand Binding to FhuA
Schematic comparison of the hydrogen bonding pattern and charge
interactions of the side chain residues of the FhuA ligand binding site
with (a) rifamycin CGP 4832, (b) albomycin (extended conformational
isomer) [7], and (c) ferricrocin [4]. The chemical structures of fer-
ricrocin, albomycin, and rifamycin CGP 4832 are shown with hydro-
gen bonds and charge interactions with side chains as dotted lines
(distances are given in A˚). Hydrogen atoms have been partly omitted.
See Table 2 for details of additional van der Waals contacts between
side chains and rifamycin CGP 4832.
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Table 3. Interactions of FhuA with its Cognate Ligands Bound to the Extracellular Pocket
Rifamycin
Side Chain Residues Ferricrocin Phenylferricrocin Albomycin* Albomycin† CGP 4832
R81 from apex A 
 
 
 
 	
Y87 from a cork domain loop 	 
 	 	 	
E98 near apex B 	 	 	 	 

G99 near apex B 
 
 
 
 

Q100 from apex B 
 
 
 
 

S101 from a cork domain loop 	 	 	 	 

F115 near apex C 	 
 	 
 

Y116 from apex C 
 
 
 
 

Y244 from L3 
 
 
 
 

W246 from L3 
 
 
 
 

Y313 from 7 
 
 
 
 

Y315 from L4 
 
 
 	 

K344 from 8 	 	 
 	 

F391 from 9 
 
 
 
 

G392 from 9 	 	 	 	 

Y393 from L5 	 	 
 
 	
Y423 from 10 	 	 	 
 

Q505 from L7 	 	 	 
 

F557 from L8 	 	 
 	 	
F558 from L8 	 	 
 	 	
F693 from L11 
 
 
 
 

Y696 from L11 	 	 	 	 

Listed are all side chains within 4 A˚ of ligand atoms: ferricrocin [4]; phenylferricrocin [7]; albomycin extended (*) and compact (†) conformational
isomers [7]; and rifamycin CGP 4832.
equivalent at high concentrations (100 g/ml); the lat- concentration dependence of CGP 4832 inhibition sug-
gests a rather high affinity of CGP 4832 to FhuA (KD forter compound is not actively transported by FhuA and
presumably permeates through the outer membrane by ferrichrome is 0.1 M [3]). It was mere coincidence
that screening rifamycin derivatives against E. coli andpassive diffusion only.
related gram-negative bacteria identified this antibiotic,
which fits snugly into the common binding site of FhuADiscussion
and is actively transported across the outer membrane.
The crystal structure of FhuA in complex with rifamycinLigand Binding and Concomitant Allosteric
Conformational Transitions CGP 4832 showed that high-affinity binding results from
the addition of morpholino and N-methyl-3-piperidyl-In contrast to rifamycin, the semisynthetic derivative
CGP 4832 binds to FhuA. Competition of ferrichrome acetoxyacetyl moieties to rifamycin. These additional
groups form most of the specific interactions with sidetransport by CGP 4832, as shown in this paper, indicates
a common binding site for both substrates, and the chains found in the extracellular pocket of FhuA. Most
transport proteins display high affinity for their cognate
ligands; however, they rarely covalently modify their
substrates and thereby impose stringent geometric con-
straints on those side chains lining the binding site.
For this reason, transporters tolerate larger structural
diversity than enzymes, as observed in the FhuA-CGP
4832 complex.
The binding of ferrichrome or albomycin to FhuA in-
duces a short NH2-terminal segment designated the
switch helix (residues 24–29) to unwind and thus dis-
place E19 approximately 17 A˚ from its unliganded C
position to a site designated the “putative channel-form-
ing segment” [4, 5, 7]. These crystallographically deter-
mined TonB-independent conformational transitions are
in accord with in vivo and in vitro data collected from
Figure 4. Destabilization of the Switch Helix upon Binding of CGP intact cells and from detergent-solubilized FhuA. Specif-
4832 ically, ligand binding reduced the efficiency of the bind-
Relative B factors of the first 21 C atoms of unliganded FhuA (closed ing of monoclonal antibodies that are sensitive to the
square) and FhuA liganded with the rifamycin CGP 4832 (closed conformation of residues 21–59 [14], enhanced the for-
circle). Relative B factors are B factors divided by the mean B factor mation of a chemically crosslinked FhuA-TonB complex
of all C atoms of the respective structure; the mean B factor for
[15], decreased the intrinsic tryptophan fluorescenceunliganded FhuA is 63 A˚2 (  13.6) and for FhuA in complex with
of FhuA [11], and caused fluorescence quenching ofrifamycin CGP 4832 is 68 A˚2 (  14.0). Residues 24–29 compose
the switch helix. fluorescein-maleimide bound to a genetically intro-
Transport of an Antibiotic by FhuA
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duced cysteine residue in the fourth extracellular loop
[12]. The translation of W22 (which in unliganded confor-
mation is buried together with the switch helix within a
hydrophobic pocket) by approximately 17 A˚ across the
periplasmic pocket of FhuA upon the binding of hydrox-
amate-type siderophores or albomycin may substan-
tially contribute to tryptophan quenching.
FhuA in complex with rifamycin CGP 4832 possesses
a conformation that lies between the unliganded and
hydroxamate bound conformations of FhuA. Apex B
moves upward to the antibiotic and causes a similar
relocation of the neighboring cork domain segments, as
observed with hydroxamate-type ligands. In contrast to
the hydroxamate-bound conformation of FhuA, apex A
does not interact with rifamycin CGP 4832; thus, the
switch helix remains wound in the CGP 4832-liganded
conformation. Nevertheless, the movement of apex B
does allosterically affect the hydrophobic pocket in
which the switch helix resides, as judged from the in-
crease in relative B factors of the C atoms. This sug-
gests that the switch helix may temporarily unwind, al-
beit with lower probability than in the hydroxamate type-
liganded conformation.
Interaction of TonB with FhuA
and the Functional Consequences
The pronounced allosteric transition observed in hydro-
xamate-type ligand binding presumably serves to recruit
the energy-transducing protein TonB to the TonB box,
its principal site of known interaction with TonB-depen-
dent transporters. Relocation of this highly conserved
segment is likely required for efficient coupling of TonB
with FhuA. This NH2-proximal region of FhuA is localized
in the periplasm and has been shown by genetic and
biochemical means to interact physically with a region
of TonB at or near residue 160 [13, 16]. The failure to
visualize this segment of FhuA (residues 6–11) in any of
the currently available electron density maps [4, 5, 7]
agrees with its apparent flexibility. However, the solution
of the three-dimensional structure of the ferric entero-
Figure 5. Ligand-Induced Fluorescence Quenchingbactin receptor FepA [17] revealed that the TonB box
Tryptophan fluorescence of solutions containing (a) FhuA and (b)assumes an extended structure.
tryptophan is shown for ferrichrome (closed square), desferriferri-Direct physical interactions between the TonB box of
chrome (closed circle), and rifamycin CGP 4832 (closed triangle).
the outer-membrane vitamin B12 transporter BtuB and The given tryptophan fluorescence values were averaged from three
a segment of TonB around residue 160 have been dem- independent experiments in which each spectrum was collected
onstrated by in vivo disulphide crosslinking [18]. Site- three times. The background fluorescence spectra of all buffers
(without added ligand) were subtracted from the collected experi-directed spin labeling and electron paramagnetic reso-
mental spectra. The emitted tryptophan fluorescence of FhuA wasnance assays have also indicated that in the unliganded
taken as 100%.conformation the TonB box of BtuB may be localized
adjacent to a helix that forms specific interactions with
side chain residues from the periplasmic turns of the  Given the TonB dependence of rifamycin CGP 4832
transport as shown in [9] and the data presented here,barrel domain of the receptor [19]. The binding of vitamin
B12 converted this segment into an extended, disor- FhuA may assume two conformations that are in equilib-
rium. The majority of FhuA molecules have wound switchdered, and highly dynamic structure that likely extends
into the periplasm to interact physically with TonB. Col- helices, while a small fraction contain unwound switch
helices. Under crystal growth conditions, this equilib-lectively, these findings support the proposal that the
unwinding of the switch helix promotes the formation rium may be skewed toward the helical conformation;
however, in vivo a small percentage of FhuA proteinsof the FhuA-TonB complex in vivo, and this may be an
essential mechanistic requirement for the coupling of may be sufficient for the formation of transport-compe-
tent complexes with TonB and may thereby sustain thethe proton motive force of the cytoplasmic membrane
with receptor-mediated ligand transport across the observed transport rate. Alternatively, the physical inter-
action of TonB with the destabilized switch helix mayouter membrane.
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Table 4. Ligand-Induced Fluorescence Quenching of Fluorescein-Maleimide-Labeled Cells
Not Preincubated Preincubated with Not Preincubated Preincubated with
FhuA with CGP 4832 1 M CGP 4832 	F (%) with Ferrichrome 10 nM Ferrichrome 	F (%)
Wildtype 16.6 16.5 0 16.2 16.3 0
C329S (C318) 25.9 23.9 8 26.4 24.0 9
C318S (C329) 43.3 34.1 21 43.1 33.7 22
D336C 94.7 62.7 34 94.3 70.7 26
E. coli UL3 cells expressing the plasmids pfhuA4 (C318S), pfhuA5 (C329S), pfhuA6 (D336C), and pfhuA8 (wild-type FhuA) were labeled as
described previously [12]. Mean relative fluorescence value prior to and following preincubation with 1 M rifamycin CGP 4832 or 10 nM
ferrichrome are shown. 	F (%) indicates the ligand-induced decrease in relative fluorescein-maleimide labeling for cells not preincubated
with 1 M rifamycin CGP 4832 or 10 nM ferrichrome [ (n 	 1)  10%].
allow for an induced fit and yield a productive complex bactericidal effects of rifamycin that is not actively trans-
ported by FhuA but instead presumably permeatesat a sufficient rate. Finally, the direct physical interaction
of the TonB box of FhuA with TonB may not be essential through the outer membrane by passive diffusion only.
These genetic data indicate that the conformation offor the transport of rifamycin CGP 4832; this would indi-
cate the presence of at least one additional site of inter- the TonB box and its physical interaction with TonB are
involved in the uptake of rifamycin CGP 4832.action between FhuA and TonB. The latter interpretation
is supported by the finding that removing the entire
cork domain from the  barrel (including the TonB box)
A Proposed Transport Mechanismgenerates a mutant FhuA protein (FhuA5-160) with re-
For integrating the available biochemical, genetic, andsidual TonB-dependent transport activity, including the
structural data, we propose the following model ofuptake of rifamycin CGP 4832 [20]. When the cork do-
TonB-dependent ligand transport. First, the binding ofmain is genetically excised, interactions between TonB
the hydroxamate-type siderophores or albomycin to theand the barrel domain of FhuA may be sufficient for the
extracellular pocket of FhuA causes a TonB-indepen-induction of a structural transition within the barrel such
dent conformational change. This change is propagatedthat the ligand is released from its residual binding site
through the outer membrane and displayed by select[20]. To further probe the functional role of the TonB
periplasmic segments of the receptor, primarily thebox in the transport of rifamycin CGP 4832, we assessed
switch helix and the TonB box. The unwinding of thea series of bacterial strains with known point muta-
switch helix and the accompanying translocation (ortions in their TonB boxes [13]; all FhuA-mediated, TonB-
possibly a change in the conformation) of the TonB box,dependent transport activities were impaired in these
alone or in combination with conformational changes ofstrains. The sensitivities of these cells to the bactericidal
periplasmic segments, may serve to recruit TonB to itseffects of rifamycin CGP 4832 were equivalent to the
site of interaction with FhuA.
Upon forming a productive complex with FhuA, TonB
transduces conformational energy to the transporter.
This event triggers a TonB-dependent conformational
change in FhuA such that the ligand binding site is dis-
rupted and the binding affinity is reduced. Disruption of
the binding site may be affected by a small shift of
apices A, B, and C toward the periplasm. This may tran-
siently alter the arrangement of the aromatic side chain
residues lining the extracellular pocket, specifically
those found on the fourth extracellular loop [12]. Further-
more, the transduction of energy causes a high-conduc-
tance channel to open within FhuA. This channel may
be physically and electrically similar to that formed upon
the irreversible adsorption of bacteriophage T5 to FhuA,
as mediated by the straight tail fiber protein pb5 [21,
22]. Although the open-channel conformation of FhuA
remains to be determined structurally, we speculate that
subtle conformational changes in the loops of the cork
domain between apex B and the periplasmic pocket
may be involved in channel formation. When viewed
along the barrel axis of unliganded FhuA and its liganded
complexes, the extracellular pocket is connected to the
periplasmic pocket in one segment (the putative chan-Figure 6. Transport Inhibition Assays with Rifamycin CGP 4832
nel-forming segment) of the barrel cross-section by a
Transport of radiolabeled [55Fe3
]-ferrichrome (2.35 M) into E. coli
10 A˚ aqueous channel. Once released from their bindingAB2847 cells in the absence (closed circle) and presence of 10 g/
sites, ligands may enter this region and reach the per-ml (closed square), 30g/ml (closed triangle), and 100g/ml (closed
diamond) of rifamycin CGP 4832. iplasmic pocket by directed diffusion along a string of
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were processed and reduced with the program XDS [27]. Initiallow-affinity binding sites. These transient ligand binding
phases for the FhuA-CGP 4832 complex were calculated with thesites could be provided by a set of strictly conserved
FhuA coordinates (1QFG) as an initial model. A model for the FhuA-side chain residues lining the interior barrel wall of the
CGP 4832 complex was built into an experimental electron density
putative channel-forming segment from the ligand bind- map with the program O [28]. The model was refined with the pro-
ing site to the periplasmic pocket of FhuA [4, 23]. gram CNS by the use of molecular dynamics and the maximum-
likelihood target [29]. After rounds of model building and structuralThe observed switch helix destabilization when rifa-
refinement, the final model contained residues 19–714, 1 lipopoly-mycin CGP 4832 binds suggests that the helix may
saccharide molecule, 1 rifamycin CGP 4832 molecule, 1 DDAO mole-briefly unwind or allow complex formation with TonB by
cule, and 178 ordered water molecules.an induced-fit mechanism at a low rate. We suggest
that this small yield of productive complexes among Isolation and Characterization of Rifamycin CGP
the rifamycin CGP 4832-loaded FhuA molecules may 4832-Resistant Bacterial Mutants
establish the transport of antibiotic molecules across To assess the sensitivity of defined FhuA mutants to rifamycin CGP
4832, we used E. coli UL3 [12] that was transformed with plasmid-the outer membrane at a rate sufficient to inhibit RNA
encoded fhuA genes with point mutations in their TonB boxes [13].polymerase activity [24]. Collectively, these results pro-
Plasmid pHK763 encoding wild-type FhuA served as a control. Wild-vide a structural basis for the superior bactericidal activ-
type and mutant fhuA genes were cloned on the same pT7-5 plas-
ity of CGP 4832 against E. coli (MIC of 0.02 g/ml) as mid. Aliquots (20 l) of a 10-fold dilution series of rifamycin CGP
compared to that of rifamycin (MIC of 4.0 g/ml). 4832 (stock solution: 0.5 mg in 1 ml of 50% methanol) and rifamycin
were spotted in parallel onto nutrient agar plates seeded with 108
cells of E. coli UL3. Diameters of the zones of growth inhibition wereEvolution of TonB-Dependent Receptors
recorded.Bacterial cells that synthesize the deletion derivative
FhuA5-160 retain a diminished level of TonB-depen-
Transport Inhibition Assays with Rifamycin CGP 4832
dent activity [20], and this finding suggests that the E. coli AB2847 cells were grown overnight on TY nutrient agar plates.
barrel domain together with TonB can constitute a func- This E. coli strain has a mutation in aroB, a gene required for the
synthesis of enterobactin, the only endogenous siderophore. If ap-tional transport system. We therefore speculate that
propriate precursors are not provided, E. coli AB2847 will transportancient gram-negative bacteria possessed a channel-
exogenously added siderophores. Colonies were suspended in 0.5forming protein similar to FhuA5-160. A string of low-
ml of M9 minimal media salts supplemented with 0.4% glucose andaffinity binding sites spanning the outer membrane may
grown to an optical density of 0.55 at 578 nm [30]. Nitrilotriacetate
have facilitated the uptake of iron-containing sidero- (8.8 l of a 10 mM solution) was added to 0.35 ml of cell suspension.
phores, as observed with glycoporin-mediated carbohy- After a 2 min incubation period, 3.5 l aliquots of rifamycin CGP
4832 (1, 3, and 10 mg/ml dissolved in 50% methanol) were addeddrate uptake [25, 26].
to the cell culture. After an additional 3 min, transport was initiated by
the addition of a mixture of 2.35M radiolabeled [55Fe3
]-ferrichromeBiological Implications
and 5 M desferriferrichrome. The cell suspension was shaken, and
50 l samples were withdrawn after 1 and 4 minute intervals, for a
Transport proteins bind their freight molecules with high total of 21 min. The samples were subsequently filtered, washed
twice with 5 ml of 0.1 M LiCl, and dried, and the [55Fe3
]-isotopeaffinity in order to achieve a high transport rate in situa-
signal was measured with a liquid scintillation counter at 37C. E.tions where molecules are available at low concentra-
coli UL3 does not synthesize a wild-type FhuA protein, and theretions only. Moreover, they avoid high selectivity in order
is no polar effect on the expression of the fhuCDB genes, whichto transport a broad range of molecules. Transport sys-
are located downstream of fhuA.
tems therefore can be cheated by molecular mimicry.
Our work has revealed structural and mechanistic de- Protein Expression, Purification, and Intrinsic Tryptophan
tails of how a molecule which is rather different in its Fluorescence Measurements
A recombinant FhuA protein was constructed by the insertion of achemical structure from natural substrates can be ac-
hexahistidine tag plus five additional linker residues (SSHHHHHHGSS)tively transported and thus act as an antibiotic at a
after residue 405 in the fhuA gene [31]. FhuA was expressed andvery low dose. We predict that in the struggle among
purified as previously described [32]. The intrinsic tryptophan fluo-
organisms such mimicry occurs quite often, and that rescence of FhuA and its complexes with rifamycin CGP 4832, with
this principle may guide researchers in the rational de- ferrichrome, or with desferriferrichrome (dissolved in 6 mM KH2PO4
velopment of new antibiotics. [pH 7.0], 0.15 M NaCl, and 0.06% N,N-dimethyldodecylamine-N-
oxide) were measured in 1.1 M FhuA solutions and, as a control,
in 10 M tryptophan solutions. FhuA (79 kDa with 9 tryptophanExperimental Procedures
residues) (1.1 M) was considered equivalent to a 10 M tryptophan
solution. All data were collected at 20C with a Fluoromax-2 spectro-Crystallization, Data Collection, and Structure Determination
photometer (Jobin Yvon-Spex Instruments) and processed with theUsing the hanging drop vapor diffusion technique, we cocrystallized
GRAMS/386 software package. A single excitation wavelength (280FhuA with rifamycin CGP 4832 by mixing equal volumes (5 l) of
nm) was used for all fluorescence measurements. Two emissionFhuA (10 mg/ml, 0.80% N,N-dimethyldecylamine-N-oxide [DDAO],
wavelengths were collected, and they correspond to the fluores-10 mM ammonium acetate [pH 8.0], 1% cis-inositol, and 1 mM
cence maxima of FhuA (335 nm) and tryptophan (355 nm).rifamycin CGP 4832) and reservoir solution (12% polyethylene glycol
[PEG] 2000 monomethyl ether, 0.1 M sodium cacodylate [pH 6.4],
20% glycerol, and 3% PEG 200). Rifamycin CGP 4832 was gener- Acknowledgments
ously provided by Dr. Reto Naef (Novartis-Pharma, Switzerland).
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with synchrotron radiation at the X-ray diffraction beam line at the Deutsche Forschungsgemeinschaft, Germany, (V.B. and W.W.) and
Natural Sciences and Engineering Research Council, Canada,Elettra synchrotron (Trieste, Italy) (Table 1). X-ray diffraction data
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